Research Grants 978 show all


$223.6M
2016

$140.6M
2017

$274M
2018

$260.7M
2019

$232M
2020

Patents 378show all

  • 78
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 60
    A61K - Preparations for medical, dental, or toilet purposes
  • 56
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 48
    C07K - Peptides
  • 31
    C12N - Microorganisms or enzymes
  • 25
    A61B - Diagnosis
  • 20
    C07D - Heterocyclic compounds
  • 8
    G16H - Healthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data
  • 7
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 7
    C07C - Acyclic or carbocyclic compounds

Publications 37,944 show all

  • 160
    Quality of Life
  • 136
    Diet
  • 123
    Health Knowledge, Attitudes, Practice
  • 121
    Attitude of Health Personnel
  • 119
    Models, Biological
  • 118
    Liver/metabolism
  • 114
    Communication
  • 113
    T-Lymphocytes/immunology
  • 106
    Genetic Predisposition to Disease
  • 104
    Biological Evolution

Clinical Trials 1,195show all

488N/A128Phase 4120Phase 251Phase 385Other

Contact Information

University of Oslo Blindern
Oslo 0316
Norway